FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950971583> ?p ?o ?g. }

• W2950971583 endingPage "1728" @default.
• W2950971583 startingPage "1718" @default.
• W2950971583 abstract "Abstract Background Anti–tumor necrosis factor (anti-TNF) drugs are highly effective in the treatment of moderate-to-severe Crohn’s disease (CD) and ulcerative colitis (UC), but they are very costly. Due to their effectiveness, they could potentially reduce future health care spending on other medical therapies, hospitalization, and surgery. The impact of downstream costs has not previously been quantified in a real-world population-based setting. Methods We used the University of Manitoba IBD Database to identify all persons in a Canadian province with CD or UC who received anti-TNF therapy between 2004 and 2016. All inpatient, outpatient, and drug costs were enumerated both in the year before anti-TNF initiation and for up to 5 years after anti-TNF initiation. Costs before and after anti-TNF initiation were compared, and multivariate linear regression analyses were performed to look for predictors of higher costs after anti-TNF initiation. Results A total of 928 people with IBD (676 CD, 252 UC) were included for analyses. The median cost of health care in the year before anti-TNF therapy was $4698 for CD vs $6364 for UC. The median cost rose to $39,749 and $49,327, respectively, in the year after anti-TNF initiation, and to $210,956 and $245,260 in the 5 years after initiation for continuous anti-TNF users. Inpatient and outpatient costs decreased in the year after anti-TNF initiation by 12% and 7%, respectively, when excluding the cost of anti-TNFs. Conclusions Direct health care expenditures markedly increase after anti-TNF initiation and continue to stay elevated over pre-initiation costs for up to 5 years, with only small reductions in the direct costs of non-drug-related health care." @default.
• W2950971583 created "2019-06-27" @default.
• W2950971583 creator A5001036733 @default.
• W2950971583 creator A5007745155 @default.
• W2950971583 creator A5013202046 @default.
• W2950971583 creator A5017421794 @default.
• W2950971583 creator A5017585326 @default.
• W2950971583 creator A5025488769 @default.
• W2950971583 creator A5027876343 @default.
• W2950971583 creator A5035437112 @default.
• W2950971583 creator A5043272946 @default.
• W2950971583 creator A5048441271 @default.
• W2950971583 creator A5055638169 @default.
• W2950971583 creator A5059484368 @default.
• W2950971583 creator A5064298425 @default.
• W2950971583 creator A5078207979 @default.
• W2950971583 creator A5082999537 @default.
• W2950971583 date "2019-06-18" @default.
• W2950971583 modified "2023-10-16" @default.
• W2950971583 title "The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease" @default.
• W2950971583 cites W1592353726 @default.
• W2950971583 cites W1975218841 @default.
• W2950971583 cites W1979434114 @default.
• W2950971583 cites W1991769947 @default.
• W2950971583 cites W2006360844 @default.
• W2950971583 cites W2030638161 @default.
• W2950971583 cites W2043162312 @default.
• W2950971583 cites W2059127937 @default.
• W2950971583 cites W2080314829 @default.
• W2950971583 cites W2081061562 @default.
• W2950971583 cites W2082916124 @default.
• W2950971583 cites W2117359708 @default.
• W2950971583 cites W2122315292 @default.
• W2950971583 cites W2127810333 @default.
• W2950971583 cites W2137775651 @default.
• W2950971583 cites W2139527007 @default.
• W2950971583 cites W2139802541 @default.
• W2950971583 cites W2142082253 @default.
• W2950971583 cites W2144370850 @default.
• W2950971583 cites W2159511764 @default.
• W2950971583 cites W2169467558 @default.
• W2950971583 cites W2171297959 @default.
• W2950971583 cites W2171341132 @default.
• W2950971583 cites W2279529970 @default.
• W2950971583 cites W2322538505 @default.
• W2950971583 cites W2589546732 @default.
• W2950971583 cites W2613173051 @default.
• W2950971583 cites W2673376286 @default.
• W2950971583 cites W2795103548 @default.
• W2950971583 cites W2801351505 @default.
• W2950971583 cites W2806215443 @default.
• W2950971583 cites W2887206736 @default.
• W2950971583 cites W4234254914 @default.
• W2950971583 doi "https://doi.org/10.1093/ibd/izz063" @default.
• W2950971583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31211836" @default.
• W2950971583 hasPublicationYear "2019" @default.
• W2950971583 type Work @default.
• W2950971583 sameAs 2950971583 @default.
• W2950971583 citedByCount "29" @default.
• W2950971583 countsByYear W29509715832019 @default.
• W2950971583 countsByYear W29509715832020 @default.
• W2950971583 countsByYear W29509715832021 @default.
• W2950971583 countsByYear W29509715832022 @default.
• W2950971583 countsByYear W29509715832023 @default.
• W2950971583 crossrefType "journal-article" @default.
• W2950971583 hasAuthorship W2950971583A5001036733 @default.
• W2950971583 hasAuthorship W2950971583A5007745155 @default.
• W2950971583 hasAuthorship W2950971583A5013202046 @default.
• W2950971583 hasAuthorship W2950971583A5017421794 @default.
• W2950971583 hasAuthorship W2950971583A5017585326 @default.
• W2950971583 hasAuthorship W2950971583A5025488769 @default.
• W2950971583 hasAuthorship W2950971583A5027876343 @default.
• W2950971583 hasAuthorship W2950971583A5035437112 @default.
• W2950971583 hasAuthorship W2950971583A5043272946 @default.
• W2950971583 hasAuthorship W2950971583A5048441271 @default.
• W2950971583 hasAuthorship W2950971583A5055638169 @default.
• W2950971583 hasAuthorship W2950971583A5059484368 @default.
• W2950971583 hasAuthorship W2950971583A5064298425 @default.
• W2950971583 hasAuthorship W2950971583A5078207979 @default.
• W2950971583 hasAuthorship W2950971583A5082999537 @default.
• W2950971583 hasBestOaLocation W29509715831 @default.
• W2950971583 hasConcept C121955636 @default.
• W2950971583 hasConcept C126322002 @default.
• W2950971583 hasConcept C144133560 @default.
• W2950971583 hasConcept C160735492 @default.
• W2950971583 hasConcept C162324750 @default.
• W2950971583 hasConcept C17991360 @default.
• W2950971583 hasConcept C1862650 @default.
• W2950971583 hasConcept C2778260677 @default.
• W2950971583 hasConcept C2779134260 @default.
• W2950971583 hasConcept C2779280984 @default.
• W2950971583 hasConcept C2780479503 @default.
• W2950971583 hasConcept C2908647359 @default.
• W2950971583 hasConcept C50522688 @default.
• W2950971583 hasConcept C6964187 @default.
• W2950971583 hasConcept C71924100 @default.
• W2950971583 hasConcept C99454951 @default.
• W2950971583 hasConceptScore W2950971583C121955636 @default.

• next